Analysis and Commentary 2/5/16 Analysis and Commentary 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More Analysis and Commentary 1/29/16 Analysis and Commentary 1/29/16 The Prompt Confirmation of a New Commissioner Read More Analysis and Commentary 1/23/16 Analysis and Commentary 1/23/16 Why Have We Watched "Cures" So Closely? Read More Analysis and Commentary 1/14/16 Analysis and Commentary 1/14/16 A Thank You ... and Now on to FY 17 Read More Analysis and Commentary 1/7/16 Analysis and Commentary 1/7/16 The Demonstration of Accountability to Multiple Stakeholders Read More Analysis and Commentary 12/18/15 Analysis and Commentary 12/18/15 And Now for FY 17 -- Starting January 12 Read More Analysis and Commentary 12/11/15 Analysis and Commentary 12/11/15 And Still We Hold Our Breath in Hope Read More Analysis and Commentary 12/4/15 Analysis and Commentary 12/4/15 When Can You "Show Me the Money"? Read More Analysis and Commentary 11/20/15 Analysis and Commentary 11/20/15 Of News, No News, and the Fine Art of Salmon Policy Riders Read More Analysis and Commentary 11/16/15 Analysis and Commentary 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More Analysis and Commentary 11/6/15 Analysis and Commentary 11/6/15 The Clock Is Ticking; Act Now Please! Read More Analysis and Commentary 10/30/15 Analysis and Commentary 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More Analysis and Commentary 10/23/15 Analysis and Commentary 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More Analysis and Commentary 10/16/15 Analysis and Commentary 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More Analysis and Commentary 10/9/15 Analysis and Commentary 10/9/15 Turmoil at the Top of the Hill Read More Analysis and Commentary 10/2/15 Analysis and Commentary 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More Analysis and Commentary 9/25/15 Analysis and Commentary 9/25/15 After the Pope, the End-Game Approacheth Read More Analysis and Commentary 9/12/15 Analysis and Commentary 9/12/15 Lobby Day Confirms General Goodwill Toward FDA Among Hill Staff Read More Analysis and Commentary 9/12/15 Analysis and Commentary 9/12/15 The Emerging Fall Fiscal Cliff and more Read More Analysis and Commentary 9/5/15 Analysis and Commentary 9/5/15 For 2015 ... A Third, and Important, Lobby Day Read More Newer Posts Older Posts
Analysis and Commentary 2/5/16 Analysis and Commentary 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More
Analysis and Commentary 1/29/16 Analysis and Commentary 1/29/16 The Prompt Confirmation of a New Commissioner Read More
Analysis and Commentary 1/23/16 Analysis and Commentary 1/23/16 Why Have We Watched "Cures" So Closely? Read More
Analysis and Commentary 1/14/16 Analysis and Commentary 1/14/16 A Thank You ... and Now on to FY 17 Read More
Analysis and Commentary 1/7/16 Analysis and Commentary 1/7/16 The Demonstration of Accountability to Multiple Stakeholders Read More
Analysis and Commentary 12/18/15 Analysis and Commentary 12/18/15 And Now for FY 17 -- Starting January 12 Read More
Analysis and Commentary 12/11/15 Analysis and Commentary 12/11/15 And Still We Hold Our Breath in Hope Read More
Analysis and Commentary 12/4/15 Analysis and Commentary 12/4/15 When Can You "Show Me the Money"? Read More
Analysis and Commentary 11/20/15 Analysis and Commentary 11/20/15 Of News, No News, and the Fine Art of Salmon Policy Riders Read More
Analysis and Commentary 11/16/15 Analysis and Commentary 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More
Analysis and Commentary 11/6/15 Analysis and Commentary 11/6/15 The Clock Is Ticking; Act Now Please! Read More
Analysis and Commentary 10/30/15 Analysis and Commentary 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More
Analysis and Commentary 10/23/15 Analysis and Commentary 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More
Analysis and Commentary 10/16/15 Analysis and Commentary 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More
Analysis and Commentary 10/9/15 Analysis and Commentary 10/9/15 Turmoil at the Top of the Hill Read More
Analysis and Commentary 10/2/15 Analysis and Commentary 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More
Analysis and Commentary 9/25/15 Analysis and Commentary 9/25/15 After the Pope, the End-Game Approacheth Read More
Analysis and Commentary 9/12/15 Analysis and Commentary 9/12/15 Lobby Day Confirms General Goodwill Toward FDA Among Hill Staff Read More
Analysis and Commentary 9/12/15 Analysis and Commentary 9/12/15 The Emerging Fall Fiscal Cliff and more Read More
Analysis and Commentary 9/5/15 Analysis and Commentary 9/5/15 For 2015 ... A Third, and Important, Lobby Day Read More
